What Is AOD 9604 Peptide?
AOD-9604 is a synthetic peptide based on the C-terminal end of human growth hormone (hGH), the section running from amino acid 176 to 191. Research in the 1990s suggested this short region of the hormone was responsible for much of its effect on fat metabolism, separate from the growth-promoting activity of the full 191 amino acid hormone. AOD-9604 is a modified version of that fragment, designed to be more stable than the native sequence.
The AOD 9604 peptide came out of work by Professor Frank Ng's group at Monash University in Melbourne, and was taken into development by the Melbourne company Metabolic Pharmaceuticals. A 2000 paper in Hormone Research, "Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone", is one of the foundational studies. For Australian researchers, it is one of the few compounds in this field with local origins.
How AOD 9604 Works: Mechanism of Action
Growth hormone has two broad kinds of activity: effects on growth, which run largely through IGF-1, and direct effects on fat metabolism. AOD-9604 was designed to isolate the second. In the published preclinical work, the fragment was studied for its effects on lipolysis (the breakdown of stored fat) and lipogenesis (the formation of new fat) in fat tissue.
The distinguishing point for research design is what AOD-9604 does not do. Unlike full-length growth hormone, it was developed to avoid the hormone's effects on growth and on IGF-1, which is why it is studied as a metabolic tool rather than a growth hormone substitute.
HGH Fragment 176-191 vs AOD 9604
The two names are often used as if they mean the same thing, but they describe different molecules. "HGH fragment 176-191" is the unmodified stretch of the growth hormone sequence. AOD-9604 is the modified analogue developed from it, with changes intended to improve stability. When you compare suppliers, check which one a listing actually describes; our vial is AOD-9604.
AOD 9604 Research, Clinical Trials and Human Studies
After the early metabolic studies in animal models, AOD-9604 was taken into human clinical trials by its Australian developer in the 2000s. It has not been approved as a medicine in Australia. The compound also appears in sports anti-doping research, where laboratories have developed methods to detect it. Browse the citations, with links to each paper, in our AOD-9604 research library.
AOD 9604 vs Retatrutide, Tirzepatide, MOTS-c and Tesamorelin
AOD-9604 is often grouped with other metabolic research compounds, but its mechanism is quite different from each of them.
| Compound | What it is | Primary target |
|---|---|---|
| AOD-9604 | Modified hGH fragment (176-191) | Fat metabolism pathways of growth hormone |
| Retatrutide | Triple incretin agonist | GIP, GLP-1 and glucagon receptors |
| Tirzepatide | Dual incretin agonist | GIP and GLP-1 receptors |
| MOTS-c | Mitochondrial-derived peptide | Encoded in mitochondrial DNA |
| Tesamorelin | GHRH analogue | Stimulates growth hormone release |
| 5-Amino-1MQ | Small molecule | Inhibits the NNMT enzyme |
Tesamorelin and AOD-9604 are both linked to the growth hormone axis, but from opposite directions: tesamorelin stimulates the release of whole growth hormone, while AOD-9604 is a fragment of it. See all metabolic research peptides.
AOD 9604 5mg and 10mg Vials
Both vials contain the same AOD-9604 from the same production process, sealed in 3 mL glass vials with lot-matched testing. Choose by how much work you have planned.
AOD 9604 5mg
The AOD 9604 5mg vial suits method development, pilot work and first orders. It is the size we suggest for labs new to AOD-9604, and its smaller fill is easy to use completely within the 28 day window after reconstitution.
It is also the better choice when AOD-9604 is one of several compounds in a study and only a modest amount of each is needed. Each 5mg vial carries a lot number matched to an independent certificate of analysis.
AOD-9604 10mg
The AOD-9604 10mg vial is designed for ongoing studies. It holds twice the fill of the 5mg vial in a single lot, so more of your work runs from one certificate of analysis, and it costs less per milligram.
Choose the 10mg vial when your protocol is fixed and the reconstituted vial will be used within 28 days. For longer programmes, the larger vial also means fewer reconstitutions and fewer lot numbers to track across your records.
Buy AOD-9604 in Australia
Chainwell Peptide supplies AOD-9604 for sale in Australia to laboratories and independent researchers. Before you buy AOD 9604 online from any supplier, check that the listing names AOD-9604 rather than the unmodified fragment, states the fill in milligrams and has a lot-matched certificate of analysis. Ours can be checked on the COA lookup page.
- Same-day dispatch on orders paid before 3pm on a business day.
- Australia-wide delivery by standard or express post.
- PayID or bank transfer, with your order number as the payment reference.
The current AOD 9604 price for each vial size is shown at the top of this page, with GST included, and shipping is charged once per order.
AOD-9604 Specifications
| Compound | AOD-9604 |
|---|---|
| Description | Modified fragment of human growth hormone, amino acids 176 to 191 |
| Origin | Developed from research at Monash University, Melbourne |
| Vial sizes | 5mg, 10mg |
| Form | Lyophilized (freeze-dried) powder |
| Container | 3 mL clear glass vial, rubber stopper, flip-off cap |
| Testing | Identity and purity by an independent laboratory, per lot |
| Diluent | Bacteriostatic water, sold separately |
| Storage | Minus 20 °C long term, 2 to 8 °C short term, protect from light |
AOD-9604 Reconstitution
AOD-9604 is supplied as a dry cake and is usually reconstituted with bacteriostatic water. Add the water slowly down the inside wall of the vial and swirl gently; shaking can damage the peptide chain. Some labs prefer 0.6% acetic acid for peptides that are slow to dissolve. A solution that stays cloudy after gentle swirling, or that forms a gel, should not be used, and the lot number should be checked against its certificate of analysis. Keep the reconstituted vial at 2 to 8 °C and use it within 28 days. Our reconstitution guide and calculator covers the steps in detail.
Research Use Only
AOD-9604 is not approved by the Therapeutic Goods Administration for any therapeutic use. Chainwell Peptide sells it strictly for laboratory and in vitro research. It is not for human or veterinary use, and we do not provide dosing advice. By ordering you agree to our terms and conditions and research use only statement.
AOD-9604 FAQ
What is AOD 9604 peptide?
+
AOD-9604 is a modified fragment of human growth hormone covering amino acids 176 to 191, the region linked to the hormone's effects on fat metabolism. It was developed from research at Monash University in Melbourne. Chainwell Peptide supplies it in 5mg and 10mg lyophilized research vials with a lot-matched certificate of analysis.
What is the difference between HGH fragment 176-191 and AOD 9604?
+
HGH fragment 176-191 is the unmodified section of the growth hormone sequence. AOD-9604 is a modified analogue developed from that fragment, with changes intended to make it more stable. The names are often used interchangeably, but they are different molecules. The Chainwell Peptide vial contains AOD-9604.
How does AOD 9604 work?
+
AOD-9604 was designed to isolate the fat metabolism activity of growth hormone from its growth-promoting activity. Preclinical studies examined its effects on lipolysis and lipogenesis in fat tissue. Unlike full-length growth hormone, it was developed to avoid effects on growth and IGF-1, which is why it is studied as a metabolic research tool.
Where can I buy AOD-9604 in Australia?
+
You can buy AOD-9604 in Australia from Chainwell Peptide in 5mg and 10mg lyophilized research vials. Each vial carries a lot number matched to an independent certificate of analysis, and orders paid before 3pm on a business day ship the same day by standard or express post.
How do you reconstitute AOD-9604?
+
AOD-9604 is usually reconstituted with bacteriostatic water, added slowly down the inside of the vial and swirled gently rather than shaken. Some labs use 0.6% acetic acid for slow-dissolving peptides. A cloudy or gelled solution should not be used. Keep the mixed vial refrigerated and use it within 28 days.








